Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 11.4 mg (equivalent: nortriptyline, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - treatment of major depression

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 28.5 mg (equivalent: nortriptyline, qty 25 mg) - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate - treatment of major depression

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - biperiden hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - flumetasone pivalate, quantity: 0.2 mg/ml; clioquinol, quantity: 10 mg/ml - ear drops - excipient ingredients: macrogol 300 - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. new indications were approved as specified in the letter of 29 june 1992 from dr alex proudfoot. indicated for the treatment of eczema of the external auditory meatus in which secondary infection with micro-organisms sensitive to clioquinol has occurred. otitis externa. otomycosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - erythromycin ethyl succinate -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - lanreotide acetate, quantity: 66.67 mg (equivalent: lanreotide, qty 60 mg) - injection, solution - excipient ingredients: glacial acetic acid; water for injections - mytolac is indicated for:,- the treatment of acromegaly when the circulating levels of growth hormone and igf-1 remain abnormal after surgery and/or radiotherapy or in patients who are dopamine agonist treatment refractory,- the treatment of symptoms of carcinoid syndrome associated with carcinoid tumours,- the treatment of gastroenteropancreatic neuroendocrine tumours (gep-nets) in adult patients with unresectable locally advanced or metastatic disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - lanreotide acetate, quantity: 133.33 mg (equivalent: lanreotide, qty 120 mg) - injection, solution - excipient ingredients: water for injections; glacial acetic acid - mytolac is indicated for:,- the treatment of acromegaly when the circulating levels of growth hormone and igf-1 remain abnormal after surgery and/or radiotherapy or in patients who are dopamine agonist treatment refractory,- the treatment of symptoms of carcinoid syndrome associated with carcinoid tumours,- the treatment of gastroenteropancreatic neuroendocrine tumours (gep-nets) in adult patients with unresectable locally advanced or metastatic disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - lanreotide acetate, quantity: 100 mg (equivalent: lanreotide, qty 90 mg) - injection, solution - excipient ingredients: water for injections; glacial acetic acid - mytolac is indicated for:,- the treatment of acromegaly when the circulating levels of growth hormone and igf-1 remain abnormal after surgery and/or radiotherapy or in patients who are dopamine agonist treatment refractory,- the treatment of symptoms of carcinoid syndrome associated with carcinoid tumours,- the treatment of gastroenteropancreatic neuroendocrine tumours (gep-nets) in adult patients with unresectable locally advanced or metastatic disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - trifluoperazine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - trifluoperazine hydrochloride -